Development of an AAV-RNAi strategy to silence the dominant variant GNAO1 c.607G>A linked to encephalopathy. - Lunev EA; Klementieva NV; Vassilieva SG; Volovikov EA; Jappy D; Savchenko IM; Svetlova EA; Polikarpova AV; Shubina MY; Spirin DM; Anufrieva KS; Lebedev PR; et al. (Gene therapy, 2025)